Hims & Hers Health Inc. (NYSE:HIMS) saw a downside of -3.71% to close Tuesday at $6.74 after subtracting -$0.26 on the day. The 5-day average trading volume is 2,617,780 shares of the company’s common stock. It has gained $7.27 in the past week and touched a new high 1 time within the past 5 days. An average of 3,982,310 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 3,306,788.
HIMS’s 1-month performance is -19.18% or -$1.52 on its low of $6.70 reached on 08/22/23. The company’s shares have touched a 52-week low of $4.01 and high of $12.34, with the stock’s rally to the 52-week high happening on 05/08/23. YTD, HIMS has achieved 5.15% or $0.33 and has reached a new high 23 times. However, the current price is down -45.38% from the 52-week high price.
Insider Transactions
HIMS stock investors last saw insider trading activity on Aug 21.Okupe Oluyemi (Chief Financial Officer) most recently sold 6,698 shares at $6.92 per share on Aug 21. This transaction cost the insider $46,319. Director, O’Keefe Lynne Chou, sold 45,748 shares at a price of $7.15 on Aug 14. Then, on Aug 08, Chief Executive Officer Dudum Andrew sold 6,900 shares at a price of $9.04 per share. This transaction amounted to $62,382.
Valuation Metrics
HIMS stock has a beta of 0.55. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 2.03 while the price-to-book (PB) in the most recent quarter is 4.38, with the price to cash flow ratio at 123.53.
Hims & Hers Health Inc.’s quick ratio for the period ended June 29 was 3.20, with the current ratio over the same period at 3.50.. In terms of profitability, the gross margin trailing 12 months is 80.30%. The trailing 12-month EBITDA margin is -11.58% while for the period ending June 29, Hims & Hers Health Inc.’s operating margin was -7.30%. The firm’s gross profit as reported stood at $408.72 million against revenue of $526.92 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -174.86% to -$7.16 million, while revenue of -$10.07 million was -40.64% off the previous quarter. Analysts expected HIMS to announce -$0.05 per share in earnings in its latest quarter, but it posted -$0.03, representing a 40.00% surprise. EBITDA for the quarter stood at more than -$8.34 million. HIMS stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 69.81 million, with total debt at $5.09 million. Shareholders hold equity totaling $211.02 million.
Let’s look briefly at Hims & Hers Health Inc. (HIMS) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 August was 24.77% to suggest the stock is trending oversold, with historical volatility in this time period at 27.92%.
The stock’s 5-day moving average is $6.89, reflecting a -6.13% or -$0.44 change from its current price. HIMS is currently trading -18.80% above its 20-day SMA, -32.80% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -25.11% and SMA200 by+57.48%.
Stochastic %K and %D was 5.04% and 4.45% and the average true range (ATR) pointed at 0.39. The RSI (14) points at 28.39%, while the 14-day stochastic is at 1.36% with the period’s ATR at 0.41. The stock’s 9-day MACD Oscillator is pointing at -0.17 and -0.45 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Hims & Hers Health Inc. (NYSE: HIMS), TD Cowen launched coverage with an Outperform rating. Analysts offering their rating for HIMS stock have a consensus rating for the stock as Overweight. Currently, 0 brokerage advisors rate HIMS as a “sell,”, while 4 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 6 have offered a “buy” rating.
What is HIMS’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $8.00 and a high of $18.00, with their median price target at $11.50. Looking at these predictions, the average price target given by analysts is for Hims & Hers Health Inc. (HIMS) stock is $12.30.
